Risk assessment in deferred and recovered donors
Autor: | Jill E. Urban, Dwight Cavanaugh, Valerie Corder, Matthew Petroll, Ellen Heck, William Timmons |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Tissue and Organ Procurement Population Biomedical Engineering Disease Risk Assessment Article Donor Selection Biomaterials 03 medical and health sciences 0302 clinical medicine Transplant surgery medicine Humans 030212 general & internal medicine Intensive care medicine education Transplantation education.field_of_study Tissue Donation: Donor Risk Assessment Interview (DRAI) screening business.industry Serologic testing Medical examiner Cell Biology Tissue Donors Tissue transplantation 030211 gastroenterology & hepatology Potential donor business Risk assessment |
Zdroj: | Cell and Tissue Banking |
ISSN: | 1573-6814 1389-9333 |
Popis: | Serologic testing and Donor Risk Assessment Interview (DRAI) combined have made tissue transplantation a frequent and safe modality for a variety of trauma and disease conditions. Donate Life America reports 30,000 tissue donors providing more than 1,750,000 tissue transplants annually. This study of 188 potential donor cases addresses issues of risk assessment in a medical examiner population in a metropolitan area, where serologic testing of deferred potential donors were compared with the DRAI screening, which determined the suitability or non-suitability for tissue procurement. Such serologic testing of deferred cases is not usually available in evaluating screening processes. This comparison gives insight into the effectiveness of the DRAI screening in deferring potential serology reactive donors. Results show in 65 cases how the DRAI screening eliminates most, but not all of the serologically reactive donors identified post recovery. The result emphasizes the need for the combined process of DRAI screening and testing to assure transplantation safety. |
Databáze: | OpenAIRE |
Externí odkaz: |